NCT02721537View on ClinicalTrials.gov

Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Concussion, Mild
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside

Three capsules, twice per day for 84 days

OTHER

Matching placebo

Three matching capsules, twice per day for 84 days

Trial Locations (2)

55455

University of Minnesota Center for Magnetic Resonance Research, Minneapolis

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

University of Minnesota

OTHER

collaborator

Thorne HealthTech, Inc

INDUSTRY

lead

Mayo Clinic

OTHER